Destiny Pharma
Pre-clinicalDevelops novel antimicrobial therapies to combat life-threatening infections and address antimicrobial resistance.
Founded
2007
Focus
Small Molecules
About
Develops novel antimicrobial therapies to combat life-threatening infections and address antimicrobial resistance.
Funding History
3Total raised: $57M
IPO$25MUndisclosedApr 15, 2021
Series B$20MUndisclosedJul 15, 2018
Series A$12MUndisclosedApr 15, 2016
Company Info
TypePrivate
Founded2007
LocationBrighton, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile